We are live on
!
Find out more
CS
Candriam SCA Portfolio holdings
AUM
$19.3B
1-Year Est. Return
39.18%
This Fund
S&P 500
This Quarter
Est. Return
+0.03%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$4B
AUM Growth
+$261M
(+7%)
Cap. Flow
+$281M
Cap. Flow
% of AUM
7.02%
Top 10 Holdings %
Top 10 Hldgs %
19.74%
Holding
679
New
127
Increased
246
Reduced
223
Closed
43
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$104M |
| 2 |
Apple
AAPL
|
+$60.7M |
| 3 |
Amazon
AMZN
|
+$47.5M |
| 4 |
American Express
AXP
|
+$28.7M |
| 5 |
Travelers Companies
TRV
|
+$27.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
First Solar
FSLR
|
+$28.1M |
| 2 |
Johnson & Johnson
JNJ
|
+$28.1M |
| 3 |
Clorox
CLX
|
+$26.2M |
| 4 |
TJX Companies
TJX
|
+$24.8M |
| 5 |
McKesson
MCK
|
+$23.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 24.39% |
| 2 | Financials | 11.87% |
| 3 | Technology | 10.68% |
| 4 | Communication Services | 10.67% |
| 5 | Consumer Discretionary | 9.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
American Tower
AMT
$77.7B
| $2.53M | 0.06% |
24,860
-6,225
| -20% | -$582K |
|
277
Citizens Financial Group
CFG
$30.4B
| $2.51M | 0.06% |
+120,570
| New | +$2.56M |
|
278
Chipotle Mexican Grill
CMG
$40.8B
| $2.49M | 0.06% |
266,100
+222,150
| +505% | +$2.11M |
|
|
S
279
DELISTED
Sprint Corporation
S
| $2.48M | 0.06% |
717,569
+339,287
| +90% | +$1.08M |
|
280
Scotiabank
BNS
$106B
| $2.48M | 0.06% |
+51,820
| New | +$2.12M |
|
|
BLUE
281
DELISTED
bluebird bio
BLUE
| $2.47M | 0.06% |
4,516
+23
| +0.5% | +$14.1K |
|
|
GHDX
282
DELISTED
Genomic Health, Inc.
GHDX
| $2.46M | 0.06% |
100,000
-28,000
| -22% | -$768K |
|
|
SWN
283
DELISTED
Southwestern Energy Company
SWN
| $2.46M | 0.06% |
306,195
+24,008
| +9% | +$184K |
|
284
Public Storage
PSA
$60.2B
| $2.44M | 0.06% |
8,884
-248
| -3% | -$62.6K |
|
285
Zoetis
ZTS
$31.6B
| $2.43M | 0.06% |
55,085
+8,826
| +19% | +$375K |
|
|
MRSH
286
Marsh
MRSH
$86.3B
| $2.4M | 0.06% |
39,766
+1,051
| +3% | +$58.9K |
|
|
MDCO
287
DELISTED
Medicines Co
MDCO
| $2.37M | 0.06% |
75,000
+11,700
| +18% | +$382K |
|
288
GameStop
GME
$9.5B
| $2.32M | 0.06% |
294,132
-486,716
| -62% | -$3.5M |
|
|
EGRX
289
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $2.32M | 0.06% |
+57,500
| New | +$3.65M |
|
290
Kimberly-Clark
KMB
$36.4B
| $2.29M | 0.06% |
17,093
-53,535
| -76% | -$6.96M |
|
|
WBA
291
DELISTED
Walgreens Boots Alliance
WBA
| $2.26M | 0.06% |
27,003
-1,304
| -5% | -$104K |
|
292
Bio-Techne
TECH
$11.2B
| $2.26M | 0.06% |
96,000
-44,440
| -32% | -$979K |
|
293
Alcoa
AA
$11.7B
| $2.24M | 0.06% |
+97,801
| New | +$1.99M |
|
294
O-I Glass
OI
$1.39B
| $2.23M | 0.06% |
+140,759
| New | +$2.02M |
|
295
Waste Management
WM
$95.9B
| $2.23M | 0.06% |
37,986
-174,189
| -82% | -$9.62M |
|
|
MRTX
296
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $2.21M | 0.06% |
104,000
-11,000
| -10% | -$246K |
|
297
MacroGenics
MGNX
$235M
| $2.2M | 0.06% |
118,000
-17,100
| -13% | -$326K |
|
|
SAGE
298
DELISTED
Sage Therapeutics
SAGE
| $2.2M | 0.06% |
69,000
-7,200
| -9% | -$253K |
|
|
ODP
299
DELISTED
ODP
ODP
| $2.19M | 0.05% |
31,039
+7,898
| +34% | +$426K |
|
|
ACHN
300
DELISTED
Achillion Pharmaceuticals
ACHN
| $2.19M | 0.05% |
285,000
-59,300
| -17% | -$434K |
|
Similar funds
PCM
A
MGP
LF
SOMRS
BPA
MIM
Candriam SCA's Q1 2016 Portfolio in Review
As of Q1 2016, Candriam SCA held 679 positions worth $4B, up 7% from $3.74B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Candriam SCA deployed $281M of net new capital in Q1 2016, opening 127 new positions and adding to 246 existing holdings. Its largest new stake was Amgen: 700,333 shares worth $104M.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 29% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was First Solar, an estimated $28.1M trimmed.
- Candriam SCA's largest Q1 2016 buy was Amgen: 700,333 shares worth $104M.
- Candriam SCA added most to Mead Johnson Nutrition Company in Q1 2016, an estimated $22.2M increase.
- Candriam SCA's biggest Q1 2016 reduction was First Solar, cutting an estimated $28.1M.
- Candriam SCA fully exited Avangrid, Inc. in Q1 2016, selling an estimated $9.6M.
- Candriam SCA's ten largest holdings make up 20% of its $4B portfolio in Q1 2016.
- Candriam SCA opened 127 new positions and closed 43 in Q1 2016.
- Candriam SCA's portfolio value rose 7% quarter-over-quarter to $4B.
Based on Candriam SCA's 13F filing for Q1 2016, filed 27 Apr 2016.